SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]
SEC Accession No. 0001193125-12-211382
Filing Date
2012-05-04
Accepted
2012-05-04 14:02:06
Documents
9
Period of Report
2012-03-31
Filing Date Changed
2012-05-04

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d329075d10q.htm 10-Q 357082
2 SECTION 302 CEO CERTIFICATION d329075dex311.htm EX-31.1 10547
3 SECTION 302 CFO CERTIFICATION d329075dex312.htm EX-31.2 10549
4 SECTION 906 CEO AND CFO CERTIFICATION d329075dex321.htm EX-32.1 5124
  Complete submission text file 0001193125-12-211382.txt   1755235

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ampe-20120331.xml EX-101.INS 207781
6 XBRL TAXONOMY EXTENSION SCHEMA ampe-20120331.xsd EX-101.SCH 11600
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ampe-20120331_cal.xml EX-101.CAL 32784
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE ampe-20120331_lab.xml EX-101.LAB 118271
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ampe-20120331_pre.xml EX-101.PRE 73303
Mailing Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111
Business Address 5445 DTC PARKWAY SUITE 925 GREENWOOD VILLAGE CO 80111 720-437-6500
Ampio Pharmaceuticals, Inc. (Filer) CIK: 0001411906 (see all company filings)

IRS No.: 260179592 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35182 | Film No.: 12813452
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1